Nautilus Biotechnology (NAUT) Enterprise Value (2020 - 2026)
Nautilus Biotechnology has reported Enterprise Value over the past 7 years, most recently at -$95.9 million for Q1 2026.
- Quarterly results put Enterprise Value at -$95.9 million for Q1 2026, up 30.94% from a year ago — trailing twelve months through Mar 2026 was -$95.9 million (up 30.94% YoY), and the annual figure for FY2025 was -$103.4 million, up 20.39%.
- Enterprise Value reached -$95.9 million in Q1 2026 per NAUT's latest filing, up from -$103.4 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$95.9 million in Q1 2026 and bottomed at -$324.1 million in Q1 2022.
- Median Enterprise Value over the past 5 years was -$167.3 million (2023), compared with a mean of -$175.9 million.
- The largest annual shift saw Enterprise Value plummeted 47423.79% in 2022 before it skyrocketed 48.37% in 2023.
- Over 5 years, Enterprise Value stood at -$184.5 million in 2022, then rose by 5.99% to -$173.4 million in 2023, then rose by 25.1% to -$129.9 million in 2024, then grew by 20.39% to -$103.4 million in 2025, then increased by 7.29% to -$95.9 million in 2026.
- Business Quant data shows Enterprise Value for NAUT at -$95.9 million in Q1 2026, -$103.4 million in Q4 2025, and -$131.4 million in Q3 2025.